List of Tables
    Table 1. Clostridium Difficile Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Clostridium Difficile Treatment Market Trends
    Table 3. Clostridium Difficile Treatment Market Drivers
    Table 4. Clostridium Difficile Treatment Market Challenges
    Table 5. Clostridium Difficile Treatment Market Restraints
    Table 6. Global Clostridium Difficile Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Clostridium Difficile Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Clostridium Difficile Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Clostridium Difficile Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Clostridium Difficile Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Clostridium Difficile Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Clostridium Difficile Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Clostridium Difficile Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Clostridium Difficile Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clostridium Difficile Treatment as of 2021)
    Table 15. Top Players of Clostridium Difficile Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Clostridium Difficile Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Clostridium Difficile Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Clostridium Difficile Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Clostridium Difficile Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Clostridium Difficile Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Clostridium Difficile Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Clostridium Difficile Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Clostridium Difficile Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Clostridium Difficile Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Clostridium Difficile Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Clostridium Difficile Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Clostridium Difficile Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Actelion Pharmaceuticals Company Details
    Table 31. Actelion Pharmaceuticals Business Overview
    Table 32. Actelion Pharmaceuticals Clostridium Difficile Treatment Product
    Table 33. Actelion Pharmaceuticals Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 34. Actelion Pharmaceuticals Recent Development
    Table 35. Merck Company Details
    Table 36. Merck Business Overview
    Table 37. Merck Clostridium Difficile Treatment Product
    Table 38. Merck Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 39. Merck Recent Development
    Table 40. Pfizer Company Details
    Table 41. Pfizer Business Overview
    Table 42. Pfizer Clostridium Difficile Treatment Product
    Table 43. Pfizer Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 44. Pfizer Recent Development
    Table 45. Summit Therapeutics Company Details
    Table 46. Summit Therapeutics Business Overview
    Table 47. Summit Therapeutics Clostridium Difficile Treatment Product
    Table 48. Summit Therapeutics Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 49. Summit Therapeutics Recent Development
    Table 50. Astellas Pharma Company Details
    Table 51. Astellas Pharma Business Overview
    Table 52. Astellas Pharma Clostridium Difficile Treatment Product
    Table 53. Astellas Pharma Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 54. Astellas Pharma Recent Development
    Table 55. CRESTOVO Company Details
    Table 56. CRESTOVO Business Overview
    Table 57. CRESTOVO Clostridium Difficile Treatment Product
    Table 58. CRESTOVO Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 59. CRESTOVO Recent Development
    Table 60. Da Volterra Company Details
    Table 61. Da Volterra Business Overview
    Table 62. Da Volterra Clostridium Difficile Treatment Product
    Table 63. Da Volterra Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 64. Da Volterra Recent Development
    Table 65. Immuron Company Details
    Table 66. Immuron Business Overview
    Table 67. Immuron Clostridium Difficile Treatment Product
    Table 68. Immuron Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 69. Immuron Recent Development
    Table 70. MGB Biopharma Company Details
    Table 71. MGB Biopharma Business Overview
    Table 72. MGB Biopharma Clostridium Difficile Treatment Product
    Table 73. MGB Biopharma Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 74. MGB Biopharma Recent Development
    Table 75. Novartis Company Details
    Table 76. Novartis Business Overview
    Table 77. Novartis Clostridium Difficile Treatment Product
    Table 78. Novartis Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 79. Novartis Recent Development
    Table 80. Otsuka Pharmaceutical Company Details
    Table 81. Otsuka Pharmaceutical Business Overview
    Table 82. Otsuka Pharmaceutical Clostridium Difficile Treatment Product
    Table 83. Otsuka Pharmaceutical Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 84. Otsuka Pharmaceutical Recent Development
    Table 85. Rebiotix Company Details
    Table 86. Rebiotix Business Overview
    Table 87. Rebiotix Clostridium Difficile Treatment Product
    Table 88. Rebiotix Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 89. Rebiotix Recent Development
    Table 90. Romark Laboratories Company Details
    Table 91. Romark Laboratories Business Overview
    Table 92. Romark Laboratories Clostridium Difficile Treatment Product
    Table 93. Romark Laboratories Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 94. Romark Laboratories Recent Development
    Table 95. Sanofi Pasteur Company Details
    Table 96. Sanofi Pasteur Business Overview
    Table 97. Sanofi Pasteur Clostridium Difficile Treatment Product
    Table 98. Sanofi Pasteur Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 99. Sanofi Pasteur Recent Development
    Table 100. Seres Therapeutics Company Details
    Table 101. Seres Therapeutics Business Overview
    Table 102. Seres Therapeutics Clostridium Difficile Treatment Product
    Table 103. Seres Therapeutics Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 104. Seres Therapeutics Recent Development
    Table 105. Takeda Company Details
    Table 106. Takeda Business Overview
    Table 107. Takeda Clostridium Difficile Treatment Product
    Table 108. Takeda Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 109. Takeda Recent Development
    Table 110. Synthetic Biologics Company Details
    Table 111. Synthetic Biologics Business Overview
    Table 112. Synthetic Biologics Clostridium Difficile Treatment Product
    Table 113. Synthetic Biologics Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 114. Synthetic Biologics Recent Development
    Table 115. Bausch Health Company Details
    Table 116. Bausch Health Business Overview
    Table 117. Bausch Health Clostridium Difficile Treatment Product
    Table 118. Bausch Health Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 119. Bausch Health Recent Development
    Table 120. Valneva Company Details
    Table 121. Valneva Business Overview
    Table 122. Valneva Clostridium Difficile Treatment Product
    Table 123. Valneva Revenue in Clostridium Difficile Treatment Business (2017-2022) & (US$ Million)
    Table 124. Valneva Recent Development
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Clostridium Difficile Treatment Product Picture
    Figure 2. Global Clostridium Difficile Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Clostridium Difficile Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Clostridium Difficile Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Clostridium Difficile Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Clostridium Difficile Treatment Market Share in Global 2017-2028
    Figure 7. Clostridium Difficile Treatment Report Years Considered
    Figure 8. Product Picture of Narrow Spectrum Antibiotics
    Figure 9. Product Picture of Broad Spectrum Antibiotics
    Figure 10. Global Clostridium Difficile Treatment Market Share by Type in 2022 & 2028
    Figure 11. Global Clostridium Difficile Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Clostridium Difficile Treatment Market Share by Type (2017-2028)
    Figure 13. United States Clostridium Difficile Treatment Market Share by Type in 2022 & 2028
    Figure 14. United States Clostridium Difficile Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Clostridium Difficile Treatment Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Clinics
    Figure 18. Product Picture of Others
    Figure 19. Global Clostridium Difficile Treatment Market Share by Application in 2022 & 2028
    Figure 20. Global Clostridium Difficile Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Clostridium Difficile Treatment Market Share by Application (2017-2028)
    Figure 22. United States Clostridium Difficile Treatment Market Share by Application in 2022 & 2028
    Figure 23. United States Clostridium Difficile Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Clostridium Difficile Treatment Market Share by Application (2017-2028)
    Figure 25. North America Clostridium Difficile Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. United States Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Clostridium Difficile Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Clostridium Difficile Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. China Taiwan Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Latin America Clostridium Difficile Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 45. Mexico Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Brazil Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Argentina Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Clostridium Difficile Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Turkey Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Saudi Arabia Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. UAE Clostridium Difficile Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Actelion Pharmaceuticals Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 53. Merck Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 54. Pfizer Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 55. Summit Therapeutics Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 56. Astellas Pharma Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 57. CRESTOVO Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 58. Da Volterra Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 59. Immuron Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 60. MGB Biopharma Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 61. Novartis Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 62. Otsuka Pharmaceutical Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 63. Rebiotix Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 64. Romark Laboratories Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 65. Sanofi Pasteur Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 66. Seres Therapeutics Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 67. Takeda Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 68. Synthetic Biologics Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 69. Bausch Health Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 70. Valneva Revenue Growth Rate in Clostridium Difficile Treatment Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed